<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>GAVILYTE - NÂ - polyethylene glycol 3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chlorideÂ powder, for solutionÂ </strong><br>GAVIS Pharmaceuticals, LLC<br></p></div>
<h1>
<span class="Bold">GaviLyte</span><span class="Bold"><span class="Sup">TM</span></span><span class="Bold"> â€“</span><span class="Bold"><span class="Sup"></span></span><span class="Bold">N with Flavor Pack</span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N is a white powder for reconstitution containing 420 g polyethylene glycol 3350, 5.72 g sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, 11.2 g sodium chloride, 1.48 g potassium chloride and one 2 g flavor pack (optional). When dissolved in water to a volume of 4 liters, GaviLyte â€“<span class="Sup"></span>N (PEG-3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> and potassium chloride for oral solution) is an isosmotic solution, for oral administration, having a pleasant mineral water taste. GaviLyte â€“<span class="Sup"></span>N is administered orally or via nasogastric tube as a gastrointestinal lavage. GaviLyte â€“<span class="Sup"></span>N Flavor Pack is available in lemon flavor. This preparation can be used without the addition of a GaviLyte â€“<span class="Sup"></span>N Flavor Pack.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N induces a <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> which rapidly cleanses the bowel, usually within four hours. The osmotic activity of polyethylene glycol 3350 and the electrolyte concentration result in virtually no net absorption or excretion of ions or water. Accordingly, large volumes may be administered without significant changes in fluid or electrolyte balance.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N is indicated for bowel cleansing prior to colonoscopy.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N is contraindicated in patients known to be hypersensitive to any of the components. GaviLyte â€“<span class="Sup"></span>N is contraindicated in patients with <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span>, <span class="product-label-link" type="condition" conceptid="4129389" conceptname="Gastrointestinal obstruction">gastrointestinal obstruction</span>, gastric retention, <span class="product-label-link" type="condition" conceptid="193242" conceptname="Perforation of intestine">bowel perforation</span>, toxic <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span> or toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N Flavor Pack is for use only in combination with the contents of the accompanying 4 liter container. No additional ingredients, e.g. flavorings, should be added to the solution. GaviLyte â€“<span class="Sup"></span>N should be used with caution in patients with severe <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>. Use of GaviLyte â€“<span class="Sup"></span>N in children younger than 2 years of age should be carefully monitored for occurrence of possible <span class="product-label-link" type="condition" conceptid="24609" conceptname="Hypoglycemia">hypoglycemia</span>, as this solution has no caloric substrate. <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">Dehydration</span> has been reported in 1 child and <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> has been reported in 3 children.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS
</span></h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2><span class="Bold Italics">General
</span></h2>
<p class="First">Patients with impaired gag reflex, <span class="product-label-link" type="condition" conceptid="372448" conceptname="Loss of consciousness">unconscious</span>, or semiconscious patients, and patients prone to <span class="product-label-link" type="condition" conceptid="4301596" conceptname="Regurgitation">regurgitation</span> or <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> should be observed during the administration of GaviLyte â€“<span class="Sup"></span>N, especially if it is administered via nasogastric tube. If a patient experiences severe <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> or <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, administration should be slowed or temporarily discontinued until the symptoms abate. If <span class="product-label-link" type="condition" conceptid="4129389" conceptname="Gastrointestinal obstruction">gastrointestinal obstruction</span> or perforation is suspected, appropriate studies should be performed to rule out these conditions before administration of GaviLyte â€“<span class="Sup"></span>N.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.2"></a><p></p>
<h2><span class="Bold Italics">Information for Patients
</span></h2>
<p class="First">GaviLyte â€“<span class="Sup"></span>N produces a watery stool which cleanses the bowel before examination. Prepare the solution according to the instructions on the bottle. It is more palatable if chilled. For best results, no solid food should be consumed during the 3 to 4 hour period before drinking the solution, but in no case should solid foods be eaten within 2 hours of taking GaviLyte â€“<span class="Sup"></span>N.</p>
<p>Adults drink 240 mL (8 oz.) every 10 minutes. Continue drinking until the watery stool is clear and free of solid matter. This usually requires at least 3 liters. Any unused portion should be discarded. Pediatric patients (aged 6 months or greater) drink 25 mL/kg/hour. Continue drinking until the watery stool is clear and free of solid matter. Any unused portion should be discarded. Rapid drinking of each portion is better than drinking small amounts continuously. The first bowel movement should occur approximately one hour after the start of GaviLyte â€“<span class="Sup"></span>N administration. You may experience some <span class="product-label-link" type="condition" conceptid="4023572" conceptname="Abdominal bloating">abdominal bloating</span> and <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> before the bowels start to move. If severe <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> or <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> occur, stop drinking temporarily or drink each portion at longer intervals until these symptoms disappear.</p>
<p>Use of GaviLyte â€“<span class="Sup"></span>N in children younger than 2 years of age should be carefully monitored for occurrence of possible <span class="product-label-link" type="condition" conceptid="24609" conceptname="Hypoglycemia">hypoglycemia</span>, as this solution has no caloric substrate. <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">Dehydration</span> has been reported in 1 child and <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span> has been reported in 3 children.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.3"></a><p></p>
<h2><span class="Bold Italics">Drug Interactions
</span></h2>
<p class="First">Oral medication administered within one hour of the start of administration of GaviLyte â€“<span class="Sup"></span>N may be <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed</span> from the gastrointestinal tract and not absorbed.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.4"></a><p></p>
<h2><span class="Bold Italics">Carcinogenesis, Mutagenesis, Impairment of Fertility
</span></h2>
<p class="First">Carcinogenic and reproductive studies with animals have not been performed.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.5"></a><p></p>
<h2><span class="Bold Italics">Pregnancy
</span></h2>
<p class="First">Category C. Animal reproduction studies have not been conducted with GaviLyte â€“<span class="Sup"></span>N. It is also not known whether GaviLyte â€“<span class="Sup"></span>N can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. GaviLyte â€“<span class="Sup"></span>N should be given to a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-7.6"></a><p></p>
<h2><span class="Bold Italics">Pediatric Use
</span></h2>
<p class="First">Safety and effectiveness of GaviLyte â€“<span class="Sup"></span>N in pediatric patients aged 6 months and older is supported by evidence from adequate and well-controlled clinical trials of GaviLyte â€“<span class="Sup"></span>N in adults with additional safety and efficacy data from published studies of similar formulations.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS
</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">abdominal fullness</span> and <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span> are the most common adverse reactions (occurring in up to 50% of patients) to administration of GaviLyte â€“<span class="Sup"></span>N. <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal cramps</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and anal irritation occur less frequently. These adverse reactions are transient and subside rapidly. Isolated cases of <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4170297" conceptname="Sniffles">rhinorrhea</span>, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span> and (rarely) <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span> have been reported which may represent <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>. Published literature contains isolated reports of serious adverse reaction following the administration of PEG-ELS products in patients over 60 years of age. These adverse events include upper GI <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> from Mallory-Weiss Tear, <span class="product-label-link" type="condition" conceptid="22955" conceptname="Perforation of esophagus">esophageal perforation</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">asystole</span>, sudden <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span> with <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>, and "butterfly-likeâ€? infiltrate on chest X-ray after <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and aspirating PEG.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N is usually administered orally, but may be given via nasogastric tube to patients who are unwilling or unable to drink the solution. Ideally, the patient should fast for approximately three or four hours prior to GaviLyte â€“<span class="Sup"></span>N administration, but in no case should solid food be given for at least two hours before the solution is given.</p>
<p><span class="Bold">Oral administration</span></p>
<p><span class="Bold">Adults:</span> At a rate of 240 mL (8 oz.) every 10 minutes, until the rectal effluent is clear or 4 liters are consumed. <span class="Bold">Pediatric Patients</span><span class="Bold">(aged 6 months or greater):</span> At a rate of 25 mL/kg/hour, until the rectal effluent is clear. Rapid drinking of each portion is preferred to drinking small amounts continuously. <span class="Bold">Nasogastric tube administration:</span><span class="Bold">Adults:</span> At a rate of 20 to 30 mL per minute (1.2 to 1.8 liters per hour). <span class="Bold">Pediatric Patients</span><span class="Bold">(aged 6 months or greater):</span> At a rate of 25 mL/kg/hour, until the rectal effluent is clear.</p>
<p>The first bowel movement should occur approximately one hour after the start of GaviLyte â€“<span class="Sup"></span>N administration. Ingestion of 4 liters of GaviLyte â€“<span class="Sup"></span>N solution prior to gastrointestinal examination produces satisfactory preparation in over 95% of patients.</p>
<p>Various regimens have been used. One method is to schedule patients for examination in midmorning or later, allowing the patients three hours for drinking and an additional one hour period for complete bowel evacuation. Another method is to administer GaviLyte â€“<span class="Sup"></span>N on the evening before the examination.</p>
<p><span class="Bold">Preparation of the solution</span>: GaviLyte â€“<span class="Sup"></span>N solution is prepared by filling the container to the 4 liter mark with water and <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">shaking</span> vigorously several times to insure that the ingredients are dissolved. Dissolution is facilitated by using lukewarm water. The solution is more palatable if chilled before administration. However, chilled solution is not recommended for infants. The reconstituted solution should be refrigerated and used within 48 hours. Discard any unused portion.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED
</span></h1>
<p class="First">GaviLyte â€“<span class="Sup"></span>N with Flavor Pack is supplied in a disposable jug, in powdered form, for oral administration as a solution following reconstitution. Each jug has an attached lemon flavor pack, in powdered form, for the addition of the flavor pack by the pharmacist prior to dispensing.</p>
<p><span class="Bold">GaviLyte â€“</span><span class="Bold"><span class="Sup"></span></span><span class="Bold">N with Flavor Pack</span>: PEG 3350 420 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 5.72 g, sodium chloride 11.2 g, potassium chloride 1.48 g and lemon flavor pack 2 g (optional). When made up to 4 liters volume with water, the solution contains PEG-3350 31.3 mmol/L, sodium 65 mmol/L, chloride 53 mmol/L, <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 17 mmol/L and potassium 5 mmol/L.</p>
<p><span class="Bold">STORAGE</span>: Store in sealed container at 25Â°C. When reconstituted, keep solution refrigerated. Use within 48 hours. Discard unused portion.</p>
<p><span class="Bold">NDC 43386-050-19</span></p>
<p><span class="Bold">Manufactured by: </span></p>
<p>Novel Laboratories, Inc.</p>
<p>Somerset, NJ 08873</p>
<p><span class="Bold">Distributed by:</span></p>
<p>GAVIS Pharmaceuticals, LLC</p>
<p>Somerset, NJ 08873</p>
<p>GLB-050-4L-02</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<h1><span class="Bold">PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
</span></h1>
<div class="Figure"><img alt="9405ab30-figure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=27195187-75a3-431f-90d9-84da1b94e849&amp;name=9405ab30-figure-01.jpg"></div>
<div class="Figure"><img alt="9405ab30-figure-02" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=27195187-75a3-431f-90d9-84da1b94e849&amp;name=9405ab30-figure-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>GAVILYTE - NÂ 		
					</strong><br><span class="contentTableReg">polyethylene glycol-3350, sodium chloride, potassium chloride and sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> powder, for solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:43386-050</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POLYETHYLENE GLYCOL 3350</strong> (POLYETHYLENE GLYCOL 3350) </td>
<td class="formItem">POLYETHYLENE GLYCOL 3350</td>
<td class="formItem">420Â g Â inÂ 438.4Â g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">11.2Â g Â inÂ 438.4Â g</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></strong> (SODIUM CATION) </td>
<td class="formItem">SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></td>
<td class="formItem">5.72Â g Â inÂ 438.4Â g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">1.48Â g Â inÂ 438.4Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALPHA-TOCOPHEROL, DL-</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SACCHARIN SODIUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MALTODEXTRIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ACACIA</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">Â Â Â Â </td>
<td class="formLabel">Score</td>
<td class="formItem">Â Â Â Â </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">LEMON</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:43386-050-19</td>
<td class="formItem">438.4 g in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA090019</td>
<td class="formItem">05/28/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>GAVIS Pharmaceuticals, LLC
							(829838551)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Novel Laboratories, Inc. (793518643)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Novel Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">793518643</td>
<td class="formItem">MANUFACTURE, REPACK</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Dow Chemical Company</td>
<td class="formItem"></td>
<td class="formItem">801038019</td>
<td class="formItem">API MANUFACTURE</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Mallinckrodt Baker Inc.</td>
<td class="formItem"></td>
<td class="formItem">001213481</td>
<td class="formItem">API MANUFACTURE</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Church and Dwight Co, Inc.</td>
<td class="formItem"></td>
<td class="formItem">001211952</td>
<td class="formItem">API MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 5/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>9405ab30-a280-4968-a72f-ec9e25b293de</div>
<div>Set id: 27195187-75a3-431f-90d9-84da1b94e849</div>
<div>Version: 1</div>
<div>Effective Time: 20090528</div>
</div>
</div>Â <div class="DistributorName">GAVIS Pharmaceuticals, LLC</div></p>
</body></html>
